Featured Session: Strategies to Create More Value When Contracting with CROs
Featured participants: Suresh Kannan, VP Products, Clinical Trial Optimization Solutions, IMS Health
Lynn Newbould, Senior Director Clinical Outsourcing and Contracts Management, Molecular Insight Pharmaceuticals, Inc.
Julia Love, Senior Consultant, Clinical Outsourcing, Millennium Pharmaceuticals, Inc.
About the session: There is a steady shift in the industry for sponsors to demand more accountability as outsourcing strategy goes beyond cost savings and into demonstrating value. Trial sponsors expect their CRO partners to very clearly state what they are going to do and how they are going to do it and then follow through while maintaining quality and staying within budget. However, the industry is still struggling to find an effective process that can engage stakeholders and still be streamlined.
• How do we move the industry away from focusing on the bottom line price during negotiations and look towards the cost effectiveness and “added value” of the outsourcing option?
• What creative solutions are there when CROs are being utilized far earlier in the process than ever before?